Lv1
30 积分 2025-11-01 加入
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
2小时前
待确认
Safety and efficacy of toripalimab plus concurrent chemoradiotherapy for locally advanced cervical cancer: a single-arm, phase Ib trial
3小时前
求助中
尼妥珠
2天前
已完结
Exploiting metabolic cell death for cancer therapy
3天前
已完结
皖公网安备34019202002308
